The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
bionomics | 392 |
merck patent | 18 |
merck & company | 14 |
ironwood pharmaceuticals | 12 |
biogen idec ma | 2 |
eclipse therapeutics | 1 |
astracarotene | 1 |
bonomics | 1 |
biononics | 1 |
bionomics | 23 |
biogen idec ma | 1 |
astracarotene | 1 |
bionomics | 36 |
merck patent | 3 |
ironwood pharmaceuticals | 1 |
merck & company | 1 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
novel anxiolytic compounds | 32 | 2006 |
combination therapy involving a vascular disrupting agent and an agent which targets hyp… 🛈 | 20 | 2012 |
substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as… 🛈 | 20 | 2006 |
amine derivatives as potassium channel blockers | 19 | 2011 |
combination therapy for treating proliferative diseases | 18 | 2009 |
a crystalline form of an anxiolytic compound | 16 | 2013 |
novel aryl potassium channel blockers and uses thereof | 16 | 2007 |
alpha7 nicotinic acetylcholine receptor modulators and uses thereof-i | 15 | 2012 |
salts, co-crystals, and polymorphs of an anxiolytic compound | 15 | 2013 |
loci for idiopathic generalized epilepsy, mutations thereof and method using same to ass… 🛈 | 14 | 1999 |